Horama Press Release
September 16, 2021

Coave Therapeutics and Théa Open Innovation sign exclusive licensing, co-development and commercialization agreement for Europe for CTx-PDE6b, a novel gene therapy candidate in retinitis pigmentosa

Coave Therapeutics and Théa Open…
read more
Horama Press Release
July 22, 2021

Coave Therapeutics Closes €33 million ($39 million) Series B Financing to Develop its Gene Therapy Pipeline and Next-Generation Vectors based on its AAV-Ligand Conjugate Platform

Coave Therapeutics Closes €33 million…
read more
Horama Press Release
May 18, 2020

HORAMA appoints life sciences veteran Benedikt Timmerman as new Chairman

HORAMA appoints life sciences veteran…
read more
Horama Press Release
May 4, 2020

HORAMA appoints industry veteran Ian Catchpole as Chief Scientific Officer

HORAMA appoints industry veteran Ian…
read more
Horama Press Release
March 19, 2020

HORAMA Signs Exclusive License Agreement with Leiden University Medical Center Targeting CRB1 Gene Mutations to Treat Inherited Retinal Dystrophies

HORAMA Signs Exclusive License Agreement…
read more
Horama Press Release
March 13, 2020

HORAMA strengthens its management team with the appointment of Rodolphe Clerval as Chief Business Officer (CBO)

HORAMA strengthens its management team…
read more